Clinical Impact of the Presence of a Diffuse Large B-Cell Lymphoma (DLBCL) Component in the Outcome of Untreated Patients with Follicular Lymphoma (FL)

被引：0
|
作者：
Magnano, Laura
Dlouhy, Ivan
Balague, Olga
Rivas-Delgado, Alfredo
Rovira, Jordina
Karube, Kennosuke
Gonzalez, Blanca
Martinez-Trillos, Alejandra
Martinez, Antonio
Delgado, Julio
Gine, Eva
Villamor, Neus
Campo, Elias
Lopez-Guillermo, Armando
机构：
来源：
BLOOD | 2016年 / 128卷 / 22期
关键词：
D O I：
10.1182/blood.V128.22.3043.3043
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3043
引用
收藏
页数：6
相关论文
共 50 条
  • [41] Impact of eligibility criteria discordance on clinical trial accrual in diffuse large B-cell lymphoma (DLBCL).
    Anderson, Clare E.
    Wang, Mei
    Wuliji, Natalie
    Patel, Anand Ashwin
    Lin, Chenyu
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [42] Genetic Instability (MSI, EMAST) in Patients with Follicular Lymphoma and Diffuse Large B-Cell Lymphoma
    Sychevskaya, Kseniia
    Risinskaya, Natalya
    Kravchenko, Sergey
    Nikulina, Elena
    Yushkova, Anna
    Magomedova, Aminat
    Babaaeva, Fatima
    Sudarikov, Andrey
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2020, 20 : S283 - S283
  • [43] Prognostic markers and angiogenesis in diffuse large B-cell lymphoma and follicular lymphoma
    Mezei, T.
    Gurzu, S.
    Raica, M.
    Cimpean, A.
    Szentirmay, J.
    Jung, J.
    VIRCHOWS ARCHIV, 2009, 455 : 17 - 18
  • [44] A Patient With Regressed Diffuse Large B-Cell Lymphoma and Aggressive Follicular Lymphoma
    Sethi, Ashish K.
    Haq, Bushra
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (05)
  • [45] Impact of Metformin Use on the Outcome of Diffuse Large B-Cell Lymphoma
    Wang, Yucai
    Maurer, Matthew
    Habermann, Thomas
    Witzig, Thomas
    Ansell, Stephen
    Nowakowski, Grzegorz
    Cerhan, James
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2018, 18 : S270 - S271
  • [46] An Open-Label Phase II Study of Buparlisib (BKM120) in Patients with Relapsed and Refractory Diffuse Large B-Cell Lymphoma (DLBCL), Mantle Cell Lymphoma (MCL) and Follicular Lymphoma (FL)
    Younes, Anas
    Salles, Gilles
    Martinelli, Giovanni
    Bociek, R. Gregory
    Barrigon, Dolores Caballero
    Gonzalez Barca, Eva
    Turgut, Mehmet
    Gerecitano, John F.
    Herbst, Fabian
    Williams, Lisa
    Mukherjee, Nabanita
    Tavorath, Ranjana
    Kim, Won Seog
    BLOOD, 2015, 126 (23)
  • [47] Clinical significance of survivin immunoexpresion in nodal diffuse large B-cell lymphoma (DLBCL)
    Cemerikic-Martinovic, V.
    Markovic, O.
    Marisavljevic, D.
    Drndarevic, N.
    Tamara, M.
    Jovanovic, D.
    VIRCHOWS ARCHIV, 2011, 459 : S31 - S31
  • [48] Autoimmune disease in patients with diffuse large B-cell lymphoma: occurrence and impact on outcome
    Morth, Charlott
    Valachis, Antonios
    Abu Sabaa, Amal
    Marshall, Katharina
    Hedstrom, Gustaf
    Flogegard, Max
    Baecklund, Eva
    Enblad, Gunilla
    ACTA ONCOLOGICA, 2019, 58 (08) : 1170 - 1177
  • [49] Primary prostatic lymphoma with components of both diffuse large B-cell lymphoma (DLBCL) and MALT lymphoma
    Petrakis, G.
    Koletsa, T.
    Karavasilis, V
    Rallis, G.
    Bobos, M.
    Karkavelas, G.
    Kostopoulos, I
    HIPPOKRATIA, 2012, 16 (01) : 86 - 89
  • [50] Expression of the Follicular Lymphoma Variant Translocation 1 Gene in Diffuse Large B-Cell Lymphoma Correlates With Subtype and Clinical Outcome
    Czuchlewski, David R.
    Csernus, Balazs
    Bubman, Darya
    Hyjek, Elizabeth
    Martin, Peter
    Chadburn, Amy
    Knowles, Daniel M.
    Cesarman, Ethel
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2008, 130 (06) : 957 - 962
12345